Tsuburai Takahiro, Tsurikisawa Naomi, Higashi Noritaka, Higashi Ai, Morita Sonoko, Fukutomi Yuma, Tanimoto Hidenori, Sekiya Kiyoshi, Oshikata Chiyako, Ono Emiko, Otomo Mamoru, Maeda Yuji, Taniguchi Masami, Ikehara Kunihiko, Akiyama Kazuo
Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital.
Arerugi. 2008 Dec;57(12):1293-301.
The fraction of exhaled nitric oxide (FeNO) is a useful marker of asthma control. The FeNO measurement with our offline method using SIEVERS bag collection kit may be more affordable, but there have been no studies to show the effect of anti-asthmatic therapy on FeNO with our offline method.
The study population comprised 36 steroid-naïve asthmatics at our outpatient clinic. We treated them according to asthma prevention and management guideline 2006, Japan. We also measured eNO levels by our offline method and spirometory on baseline, 4weeks, and 12 weeks of treatment.
All asthmatics were symptom-free on 12 weeks of treatment. The levels of FeNO FEV1/FVC were significantly decreased on 4 weeks and 12 weeks of treatment, compared with that on first visit. We classified the subjects into two groups; (A) FEV1/FVC <70% (n=11) or (B) FEV1/FVC > or =70% (n=25) on baseline. In (A) group, the level of FeNO and FEV1/FVC were significantly improved on 4 and 12 weeks of treatment. In (B) group, on 4 weeks of treatment, the level of FEV1/FVC was significantly increased but the level of FeNO was not significantly changed. On 12 weeks of treatment, the levels of FeNO was significantly decreased, but the level of FEV1/FVC was not significantly changed.
The levels of FeNO were decreased by antiasthmatic therapy, so that offline monitoring of eNO will facilitate the management of bronchial asthma in patients treated with these drugs.
呼出一氧化氮分数(FeNO)是哮喘控制的一个有用标志物。使用SIEVERS袋收集试剂盒的离线方法测量FeNO可能更经济实惠,但尚无研究表明抗哮喘治疗对采用我们的离线方法测量的FeNO的影响。
研究人群包括我们门诊的36名未使用过类固醇的哮喘患者。我们根据2006年日本哮喘预防和管理指南对他们进行治疗。我们还在治疗的基线、4周和12周时,通过我们的离线方法和肺量计测量呼出一氧化氮(eNO)水平。
所有哮喘患者在治疗12周时均无症状。与首次就诊时相比,治疗4周和12周时FeNO、FEV1/FVC水平显著降低。我们将受试者分为两组;(A)基线时FEV1/FVC<70%(n=11)或(B)基线时FEV1/FVC≥70%(n=25)。在(A)组中,治疗4周和12周时FeNO和FEV1/FVC水平显著改善。在(B)组中,治疗4周时,FEV1/FVC水平显著升高,但FeNO水平无显著变化。治疗12周时,FeNO水平显著降低,但FEV1/FVC水平无显著变化。
抗哮喘治疗可降低FeNO水平,因此离线监测eNO将有助于使用这些药物治疗的支气管哮喘患者的管理。